BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14527961)

  • 1. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
    Jelezarova E; Luginbuehl A; Lutz HU
    J Biol Chem; 2003 Dec; 278(51):51806-12. PubMed ID: 14527961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.
    Jelezarova E; Vogt A; Lutz HU
    Biochem J; 2000 Jul; 349(Pt 1):217-23. PubMed ID: 10861231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
    Fries LF; Prince GM; Gaither TA; Frank MM
    J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F; Muñoz E; Vidarte L; Pastor C
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes.
    Lutz HU; Stammler P; Jelezarova E; Nater M; Späth PJ
    Blood; 1996 Jul; 88(1):184-93. PubMed ID: 8704173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
    Barrio E; Antón LC; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1991 Feb; 21(2):343-9. PubMed ID: 1999223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
    Nilsson-Ekdahl K; Nilsson B
    Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly and regulation of the complement amplification loop in blood: the role of C3b-C3b-IgG complexes.
    Jelezarova E; Lutz HU
    Mol Immunol; 1999; 36(13-14):837-42. PubMed ID: 10698337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
    Fries LF; Gaither TA; Hammer CH; Frank MM
    J Exp Med; 1984 Dec; 160(6):1640-55. PubMed ID: 6239898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.
    Sahu A; Pangburn MK
    J Biol Chem; 1994 Nov; 269(46):28997-9002. PubMed ID: 7961863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    Medof ME; Iida K; Mold C; Nussenzweig V
    J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.
    Lutz HU
    Adv Exp Med Biol; 2012; 750():186-96. PubMed ID: 22903675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of C3b inhibition of immune complex induced C1 activation.
    Ziccardi RJ
    Mol Immunol; 1988 Dec; 25(12):1339-46. PubMed ID: 3237217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.
    Pangburn MK; Müller-Eberhard HJ
    Ann N Y Acad Sci; 1983; 421():291-8. PubMed ID: 6586103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential formation of C3b-IgG complexes in vitro and in vivo from nascent C3b and naturally occurring anti-band 3 antibodies.
    Lutz HU; Stammler P; Fasler S
    J Biol Chem; 1993 Aug; 268(23):17418-26. PubMed ID: 8349625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of complement C3b provides insights into complement activation and regulation.
    Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
    Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.